TENAX THERAPEUTICS, INC. Quarterly Debt-to-equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tenax Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q4 2011 to Q3 2024.
  • Tenax Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 7.83 %, a 27.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 7.83 -2.91 -27.1% Sep 30, 2024
Q2 2024 19.6 +5.87 +42.9% Jun 30, 2024
Q1 2024 15.6 -4.2 -21.2% Mar 31, 2024
Q4 2023 12.8 -33.5 -72.3% Dec 31, 2023
Q3 2023 10.7 -26.9 -71.4% Sep 30, 2023
Q2 2023 13.7 -22.2 -61.8% Jun 30, 2023
Q1 2023 19.8 -28 -58.5% Mar 31, 2023
Q4 2022 46.3 +7.01 +17.9% Dec 31, 2022
Q3 2022 37.6 -3.76 -9.09% Sep 30, 2022
Q2 2022 35.9 -4.62 -11.4% Jun 30, 2022
Q1 2022 47.8 +5.84 +13.9% Mar 31, 2022
Q4 2021 39.3 -7.82 -16.6% Dec 31, 2021
Q3 2021 41.4 -9.97 -19.4% Sep 30, 2021
Q2 2021 40.5 -11.4 -22% Jun 30, 2021
Q1 2021 42 +8.84 +26.7% Mar 31, 2021
Q4 2020 47.1 +26.6 +130% Dec 31, 2020
Q3 2020 51.3 +38 +285% Sep 30, 2020
Q2 2020 51.9 +40 +336% Jun 30, 2020
Q1 2020 33.2 +21.2 +176% Mar 31, 2020
Q4 2019 20.5 +10.2 +98.6% Dec 31, 2019
Q3 2019 13.3 +3.94 +42% Sep 30, 2019
Q2 2019 11.9 +3.02 +34% Jun 30, 2019
Q1 2019 12 +0.67 +5.91% Mar 31, 2019
Q4 2018 10.3 -10.1 -49.5% Dec 31, 2018
Q3 2018 9.38 -17.7 -65.3% Sep 30, 2018
Q2 2018 8.87 -20.8 -70.1% Jun 30, 2018
Q1 2018 11.3 -17.8 -61.1% Mar 31, 2018
Q4 2017 20.4 -7.02 -25.6% Dec 31, 2017
Q3 2017 27.1 +2.21 +8.89% Sep 30, 2017
Q2 2017 29.6 +7.29 +32.6% Jun 30, 2017
Q1 2017 29.1 +9.06 +45.2% Mar 31, 2017
Q4 2016 27.4 +9.21 +50.5% Dec 31, 2016
Q3 2016 24.9 +8.24 +49.6% Sep 30, 2016
Q2 2016 22.4 +6.47 +40.8% Jun 30, 2016
Q1 2016 20 +5.35 +36.4% Mar 31, 2016
Q4 2015 18.2 +4.72 +34.9% Dec 31, 2015
Q3 2015 16.6 +3.52 +26.9% Oct 31, 2015
Q2 2015 15.9 +2.94 +22.7% Jul 31, 2015
Q1 2015 14.7 -2.76 -15.8% Apr 30, 2015
Q4 2014 13.5 -32.2 -70.4% Jan 31, 2015
Q3 2014 13.1 -2.61K -99.5% Oct 31, 2014
Q2 2014 12.9 +792 Jul 31, 2014
Q1 2014 17.5 +483 Apr 30, 2014
Q4 2013 45.7 +746 Jan 31, 2014
Q3 2013 2.63K +3.7K Oct 31, 2013
Q2 2013 -779 -326 -71.8% Jul 31, 2013
Q1 2013 -466 -49.2 -11.8% Apr 30, 2013
Q4 2012 -700 -403 -136% Jan 31, 2013
Q3 2012 -1.08K Oct 31, 2012
Q2 2012 -453 Jul 31, 2012
Q1 2012 -416 Apr 30, 2012
Q4 2011 -297 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.